Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 9-fluoro-11 Beta,16 Alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone, 21-(3,3-dimethylbutyrate)
2. Aristospan
1. 5611-51-8
2. Aristospan
3. Lederspan
4. Tatba
5. Cl 34433
6. Tiamcinoloni Hexacetonidum [inn]
7. Chebi:9670
8. I7gt1u99y9
9. [2-[(1s,2s,4r,8s,9s,11s,12r,13s)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 3,3-dimethylbutanoate
10. Aristospan (tn)
11. Pregna-1,4-diene-3,20-dione,21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11b,16a)-
12. Triamcinolone Esacetonide
13. Tiamcinoloni Hexacetonidum
14. Triamcinoloni Hexacetonidum
15. Hexacetonide De Triamcinolone
16. Hexacetonido De Triancinolona
17. Unii-i7gt1u99y9
18. Triamcinolone Esacetonide [dcit]
19. Ncgc00182544-01
20. (11?,16?)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
21. Einecs 227-031-4
22. Brn 1413888
23. Triamcinoloni Hexacetonidum [inn-latin]
24. Cl-34433
25. Hexacetonide De Triamcinolone [inn-french]
26. Triamcinolone-hexacetonide
27. Hexacetonido De Triancinolona [inn-spanish]
28. Triamcinolone Hexace-tonide
29. Schembl7543
30. Triamcinolone Hexacetonide [usan:usp:inn:ban]
31. Dsstox_cid_28560
32. Dsstox_rid_82832
33. Dsstox_gsid_48634
34. 5-19-06-00569 (beilstein Handbook Reference)
35. Triamcinolonehexacetonide
36. Chembl1200878
37. Dtxsid0048634
38. 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone 21-(3,3-dimethylbutyrate)
39. Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11.beta.,16.alpha.)-
40. Zinc4097475
41. Tox21_112979
42. Hy-u00103
43. Triamcinolone Hexacetonide (usp/inn)
44. Cs-7139
45. Triamcinolone Hexacetonide [mi]
46. Triamcinolone Hexacetonide [inn]
47. Triamcinolone Hexacetonide [usan]
48. 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone 21-(3,3-dimethylbutyrate)
49. Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
50. Triamcinolone Hexacetonide [mart.]
51. Triamcinolone Hexacetonide [vandf]
52. Cas-5611-51-8
53. Triamcinolone Hexacetonide [usp-rs]
54. Triamcinolone Hexacetonide [who-dd]
55. C08185
56. D00985
57. Triamcinolone Hexacetonide [orange Book]
58. Triamcinolone Hexacetonide [ep Monograph]
59. Triamcinolone Hexacetonide [usp Impurity]
60. Triamcinolone Hexacetonide [usp Monograph]
61. Q1593246
62. (11beta,16alpha)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione
63. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, Cyclic 16,17-acetal With Acetone, 21-(3,3-dimethylbutyrate)
64. Pregna-1,4-diene-3,20-dione,21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11b,16a)-
Molecular Weight | 532.6 g/mol |
---|---|
Molecular Formula | C30H41FO7 |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 532.28363180 g/mol |
Monoisotopic Mass | 532.28363180 g/mol |
Topological Polar Surface Area | 99.1 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 1130 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
89
PharmaCompass offers a list of Triamcinolone Hexacetonide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Triamcinolone Hexacetonide manufacturer or Triamcinolone Hexacetonide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Triamcinolone Hexacetonide manufacturer or Triamcinolone Hexacetonide supplier.
PharmaCompass also assists you with knowing the Triamcinolone Hexacetonide API Price utilized in the formulation of products. Triamcinolone Hexacetonide API Price is not always fixed or binding as the Triamcinolone Hexacetonide Price is obtained through a variety of data sources. The Triamcinolone Hexacetonide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aristospan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aristospan, including repackagers and relabelers. The FDA regulates Aristospan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aristospan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aristospan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aristospan supplier is an individual or a company that provides Aristospan active pharmaceutical ingredient (API) or Aristospan finished formulations upon request. The Aristospan suppliers may include Aristospan API manufacturers, exporters, distributors and traders.
click here to find a list of Aristospan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aristospan DMF (Drug Master File) is a document detailing the whole manufacturing process of Aristospan active pharmaceutical ingredient (API) in detail. Different forms of Aristospan DMFs exist exist since differing nations have different regulations, such as Aristospan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aristospan DMF submitted to regulatory agencies in the US is known as a USDMF. Aristospan USDMF includes data on Aristospan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aristospan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aristospan suppliers with USDMF on PharmaCompass.
A Aristospan CEP of the European Pharmacopoeia monograph is often referred to as a Aristospan Certificate of Suitability (COS). The purpose of a Aristospan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aristospan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aristospan to their clients by showing that a Aristospan CEP has been issued for it. The manufacturer submits a Aristospan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aristospan CEP holder for the record. Additionally, the data presented in the Aristospan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aristospan DMF.
A Aristospan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aristospan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Aristospan suppliers with CEP (COS) on PharmaCompass.
A Aristospan written confirmation (Aristospan WC) is an official document issued by a regulatory agency to a Aristospan manufacturer, verifying that the manufacturing facility of a Aristospan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Aristospan APIs or Aristospan finished pharmaceutical products to another nation, regulatory agencies frequently require a Aristospan WC (written confirmation) as part of the regulatory process.
click here to find a list of Aristospan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aristospan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aristospan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aristospan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aristospan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aristospan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aristospan suppliers with NDC on PharmaCompass.
Aristospan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aristospan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aristospan GMP manufacturer or Aristospan GMP API supplier for your needs.
A Aristospan CoA (Certificate of Analysis) is a formal document that attests to Aristospan's compliance with Aristospan specifications and serves as a tool for batch-level quality control.
Aristospan CoA mostly includes findings from lab analyses of a specific batch. For each Aristospan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aristospan may be tested according to a variety of international standards, such as European Pharmacopoeia (Aristospan EP), Aristospan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aristospan USP).